30 related articles for article (PubMed ID: 15669179)
1. Fenofibrate Downregulates NF-κB Signaling to Inhibit Pro-inflammatory Cytokine Secretion in Human THP-1 Macrophages and During Primary Biliary Cholangitis.
Gallucci GM; Alsuwayt B; Auclair AM; Boyer JL; Assis DN; Ghonem NS
Inflammation; 2022 Dec; 45(6):2570-2581. PubMed ID: 35838934
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors α and γ are linked with alcohol consumption in mice and withdrawal and dependence in humans.
Blednov YA; Benavidez JM; Black M; Ferguson LB; Schoenhard GL; Goate AM; Edenberg HJ; Wetherill L; Hesselbrock V; Foroud T; Harris RA
Alcohol Clin Exp Res; 2015 Jan; 39(1):136-45. PubMed ID: 25516156
[TBL] [Abstract][Full Text] [Related]
3. Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes.
Deehan R; Maerz-Weiss P; Catlett NL; Steiner G; Wong B; Wright MB; Blander G; Elliston KO; Ladd W; Bobadilla M; Mizrahi J; Haefliger C; Edgar A
PLoS One; 2012; 7(4):e35012. PubMed ID: 22514701
[TBL] [Abstract][Full Text] [Related]
4. Pioglitazone Ameliorates Acute Endotoxemia-Induced Acute on Chronic Renal Dysfunction in Cirrhotic Ascitic Rats.
Liu SY; Huang CC; Huang SF; Liao TL; Kuo NR; Yang YY; Li TH; Liu CW; Hou MC; Lin HC
Cells; 2021 Nov; 10(11):. PubMed ID: 34831270
[TBL] [Abstract][Full Text] [Related]
5. Modulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment.
Mangan S; Clancy P; Golledge J
Thromb Res; 2008; 121(6):827-34. PubMed ID: 17869327
[TBL] [Abstract][Full Text] [Related]
6. The Role of NF-κB, PPAR-α, and PPAR-γ in Older Adults with Metabolic Syndrome.
Demirdağ F; Yavuzer S; Cengiz M; Yavuzer H; Kara Z; Ayvacı A; Avcı S; Yürüyen M; Uzun H; Altıparmak MR; Döventaş A; Erdinçler DS
Horm Metab Res; 2023 Oct; 55(10):733-740. PubMed ID: 37308136
[TBL] [Abstract][Full Text] [Related]
7. The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats.
Stunes AK; Westbroek I; Gustafsson BI; Fossmark R; Waarsing JH; Eriksen EF; Petzold C; Reseland JE; Syversen U
BMC Endocr Disord; 2011 May; 11():11. PubMed ID: 21615901
[TBL] [Abstract][Full Text] [Related]
8. A reverse translational study of PPAR-α agonist efficacy in human and rodent models relevant to alcohol use disorder.
Mason BJ; Estey D; Roberts A; de Guglielmo G; George O; Light J; Stoolmiller M; Quello S; Skinner M; Shadan F; Begovic A; Kyle MC; Harris RA
Neurobiol Stress; 2024 Mar; 29():100604. PubMed ID: 38292518
[TBL] [Abstract][Full Text] [Related]
9. Repositioning of the Antihyperlipidemic Drug Fenofibrate for the Management of
Guerra RM; Figueras MJ; Pujol-Bajador I; Fernández-Bravo A
Microorganisms; 2024 Feb; 12(3):. PubMed ID: 38543516
[TBL] [Abstract][Full Text] [Related]
10. Epoxyeicosatrienoic acids protect rat hearts against tumor necrosis factor-α-induced injury.
Zhao G; Wang J; Xu X; Jing Y; Tu L; Li X; Chen C; Cianflone K; Wang P; Dackor RT; Zeldin DC; Wang DW
J Lipid Res; 2012 Mar; 53(3):456-466. PubMed ID: 22223859
[TBL] [Abstract][Full Text] [Related]
11. Molecular determinants of the cardiometabolic phenotype.
de las Fuentes L; de Simone G; Arnett DK; Dávila-Román VG
Endocr Metab Immune Disord Drug Targets; 2010 Jun; 10(2):109-23. PubMed ID: 20384572
[TBL] [Abstract][Full Text] [Related]
12. Minireview: Won't get fooled again: the nonmetabolic roles of peroxisome proliferator-activated receptors (PPARs) in the heart.
Lockyer P; Schisler JC; Patterson C; Willis MS
Mol Endocrinol; 2010 Jun; 24(6):1111-9. PubMed ID: 20016041
[TBL] [Abstract][Full Text] [Related]
13. Vascular and metabolic effects of treatment of combined hyperlipidemia: focus on statins and fibrates.
Koh KK; Quon MJ; Rosenson RS; Chung WJ; Han SH
Int J Cardiol; 2008 Feb; 124(2):149-59. PubMed ID: 17658632
[TBL] [Abstract][Full Text] [Related]
14. Global gene expression analysis of the mouse colonic mucosa treated with azoxymethane and dextran sodium sulfate.
Suzuki R; Miyamoto S; Yasui Y; Sugie S; Tanaka T
BMC Cancer; 2007 May; 7():84. PubMed ID: 17506908
[TBL] [Abstract][Full Text] [Related]
15. Effect of peroxisome proliferator-activated receptor activators on tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Ye P; Fang H; Zhou X; He YL; Liu YX
Chin Med Sci J; 2004 Dec; 19(4):243-7. PubMed ID: 15669179
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor-gamma ligands 15-deoxy-delta(12,14)-prostaglandin J2 and pioglitazone inhibit hydroxyl peroxide-induced TNF-alpha and lipopolysaccharide-induced CXC chemokine expression in neonatal rat cardiac myocytes.
Liu J; Xia Q; Zhang Q; Li H; Zhang J; Li A; Xiu R
Shock; 2009 Sep; 32(3):317-24. PubMed ID: 19174742
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced tumor necrosis factor-alpha expression in neonatal rat cardiac myocytes.
Takano H; Nagai T; Asakawa M; Toyozaki T; Oka T; Komuro I; Saito T; Masuda Y
Circ Res; 2000 Sep; 87(7):596-602. PubMed ID: 11009565
[TBL] [Abstract][Full Text] [Related]
18. Whole grape intake impacts cardiac peroxisome proliferator-activated receptor and nuclear factor kappaB activity and cytokine expression in rats with diastolic dysfunction.
Seymour EM; Bennink MR; Watts SW; Bolling SF
Hypertension; 2010 May; 55(5):1179-85. PubMed ID: 20231522
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
Liang F; Wang F; Zhang S; Gardner DG
Endocrinology; 2003 Sep; 144(9):4187-94. PubMed ID: 12933694
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
